0.330
0.01 (1.54%)
| Previous Close | 0.325 |
| Open | 0.325 |
| Volume | 1,150,798 |
| Avg. Volume (3M) | 364,073 |
| Market Cap | 79,609,528 |
| Price / Sales | 5.03 |
| Price / Book | 1.67 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Profit Margin | -27.36% |
| Operating Margin (TTM) | -29.30% |
| Diluted EPS (TTM) | -0.030 |
| Quarterly Revenue Growth (YOY) | 15.70% |
| Total Debt/Equity (MRQ) | 2.45% |
| Current Ratio (MRQ) | 2.25 |
| Operating Cash Flow (TTM) | 3.45 M |
| Levered Free Cash Flow (TTM) | 5.65 M |
| Return on Assets (TTM) | -8.37% |
| Return on Equity (TTM) | -14.32% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (AU) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | MACH7 FPO [M7T] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 2.0 |
| Average | 1.50 |
|
Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 27.06% |
| % Held by Institutions | 23.95% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |